U.S. IPO Weekly Recap: CRISPR Biotech Pops 44% As More Names Join The IPO Pipeline
AI Summary
CRISPR Biotech's IPO saw a significant 44% increase as more companies joined the IPO pipeline in the United States. The article reviews the recent activity in the U.S. IPO market focusing on biotech firms.